Literature DB >> 3377561

Biological markers in epidemiologic research.

B S Hulka1, T Wilcosky.   

Abstract

This paper identifies some of the issues relevant to the use of biological markers in epidemiologic research. Foremost among these are clarity of definitions and marker classification. Illustrations of markers in the categories of internal dose, biological effective dose, biological response, disease, and susceptibility are presented with a theoretical model for the interrelationship among these. Issues faced by epidemiologists in selecting markers for specific studies concern exposure complexity, marker specificity, marker persistence, time to appearance, and the use of target vs. surrogate biological media. Feasibility issues concern sample collection, transport, storage, and characteristics of the laboratory assay. The rationale for biological markers in epidemiologic research is strong in that markers have the potential for (1.) improving the accuracy of our "exposure variables," (2.) permitting the identification of preclinical disease and providing opportunities for prevention, (3.) allowing for more homogeneous and etiologically relevant classifications of disease, and (4.) enhancing our understanding of the biological processes leading to disease occurrence, thereby strengthening the interpretation of epidemiologic data and the theoretical framework from which we formulate research questions.

Mesh:

Substances:

Year:  1988        PMID: 3377561     DOI: 10.1080/00039896.1988.9935831

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  14 in total

1.  Relation between lung asbestos fibre burden and exposure indices based on job history.

Authors:  K Takahashi; B W Case; A Dufresne; R Fraser; T Higashi; J Siemiatycki
Journal:  Occup Environ Med       Date:  1994-07       Impact factor: 4.402

Review 2.  Cancer biomarkers: selecting the right drug for the right patient.

Authors:  Gary J Kelloff; Caroline C Sigman
Journal:  Nat Rev Drug Discov       Date:  2012-02-10       Impact factor: 84.694

Review 3.  The biological exposure indices: a key component in protecting workers from toxic chemicals.

Authors:  M S Morgan
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

Review 4.  Utilization of biomarker data for clinical and environmental intervention.

Authors:  D C Christiani
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

Review 5.  Oncogene proteins as biomarkers in the molecular epidemiology of occupational carcinogenesis. The example of the ras oncogene-encoded p21 protein.

Authors:  P W Brandt-Rauf
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

6.  Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.

Authors:  Silvia A Mandel; Micaela Morelli; Ilan Halperin; Amos D Korczyn
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

7.  Dissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers.

Authors:  Brian Dean
Journal:  Schizophr Res Treatment       Date:  2011-06-18

Review 8.  Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker.

Authors:  J C Semenza; L H Weasel
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

9.  Using reproductive effect markers to observe subclinical events, reduce misclassification, and explore mechanism.

Authors:  M C Hatch; G Friedman-Jimenez
Journal:  Environ Health Perspect       Date:  1991-01       Impact factor: 9.031

Review 10.  The potential of exposure biomarkers in epidemiologic studies of reproductive health.

Authors:  C J Hogue; M A Brewster
Journal:  Environ Health Perspect       Date:  1991-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.